Challenging Antiplatelet Therapy for Small Vessel Stroke Through Genetics

Stroke. 2024 Apr;55(4):943-945. doi: 10.1161/STROKEAHA.124.046111. Epub 2024 Mar 25.

Authors

Guido J Falcone^{1

2}, Daniel Woo³

Affiliations

¹ Department of Neurology (G.J.F.), Yale School of Medicine, New Haven, CT.
² Center for Brain and Mind Health (G.J.F.), Yale School of Medicine, New Haven, CT.
³ Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, OH (D.W.).

PMID: 38527142
DOI: 10.1161/STROKEAHA.124.046111

No abstract available

Keywords: Editorials; antiplatelet treatment; genomics; lacunar stroke; mendelian randomization.

Publication types

Editorial

MeSH terms

Aspirin / therapeutic use
Cerebral Small Vessel Diseases*
Genome-Wide Association Study
Humans
Platelet Aggregation Inhibitors / therapeutic use
Stroke* / drug therapy
Stroke* / genetics
Stroke, Lacunar* / therapy

Substances

Platelet Aggregation Inhibitors
Aspirin